Old Web
English
Sign In
Acemap
>
Paper
>
964MO Entinostat, nivolumab and ipilimumab in advanced HER2-negative breast cancer (ETCTN-9844)
964MO Entinostat, nivolumab and ipilimumab in advanced HER2-negative breast cancer (ETCTN-9844)
2021
E.T. Roussos Torres
J Leatherman
Christine Rafie
Adam Brufsky
Patricia LoRusso
Joseph Paul Eder
Vincent Chung
Y. Yuan
Melinda Downs
A. O'Connor
Richard Piekarz
Howard Streicher
Michelle A. Rudek
Qingfeng Zhu
Elana J. Fertig
Robert A. Anders
Ashley Cimino-Mathews
Elizabeth M. Jaffee
Vered Stearns
Rm Connolly
Keywords:
HER2 negative
Ipilimumab
Breast cancer
Oncology
Entinostat
Nivolumab
Medicine
Internal medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]